New WHO guidelines on the management of pregnancy and breastfeeding in the context of Ebola

Furthermore, in the context of rigorous research or in accordance with the Consultation on Monitored Emergency Use of Unregistered and Investigational Interventions (known as MEURI) protocol,4 investigational therapies REGN-EB3 or mAb114 can be offered to pregnant women with Ebola virus disease. [.....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet infectious diseases 2020-07, Vol.20 (7), p.766-767
Hauptverfasser: Thorson, Anna E, Foeller, Megan E, Caluwaerts, Severine, Ribeiro do Valle, Carolina, Crozier, Ian, Deen, Gibrilla, Dixit, Devika, Godwin, Chrissy, Okong, Pius, Esteves Soeiro, Rachel, Sousa, João Paulo, van Herp, Michel, Bucagu, Maurice, Costa, Alejandro, Foeller, Megan, Formenty, Pierre, Gill, Roopan, Kim, Caron, Kini, Brigitte, Legand, Anais, Oladapo, Olufemi, Ouedraogo, Leopold, Perkins, Mark, Thorson, Anne, Titulaer, Patricia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 767
container_issue 7
container_start_page 766
container_title The Lancet infectious diseases
container_volume 20
creator Thorson, Anna E
Foeller, Megan E
Caluwaerts, Severine
Ribeiro do Valle, Carolina
Crozier, Ian
Deen, Gibrilla
Dixit, Devika
Godwin, Chrissy
Okong, Pius
Esteves Soeiro, Rachel
Sousa, João Paulo
van Herp, Michel
Bucagu, Maurice
Costa, Alejandro
Foeller, Megan
Formenty, Pierre
Gill, Roopan
Kim, Caron
Kini, Brigitte
Legand, Anais
Oladapo, Olufemi
Ouedraogo, Leopold
Perkins, Mark
Thorson, Anne
Titulaer, Patricia
description Furthermore, in the context of rigorous research or in accordance with the Consultation on Monitored Emergency Use of Unregistered and Investigational Interventions (known as MEURI) protocol,4 investigational therapies REGN-EB3 or mAb114 can be offered to pregnant women with Ebola virus disease. [...]2019, most pregnant women with Ebola virus disease were denied investigational therapeutics because of a paucity of drug safety data and concern for fetal harm. All pregnant women with acute Ebola virus disease should be cared for by use of both standard and Ebola-specific infection prevention and control measures, and all pregnant women who have recovered from Ebola virus disease (and who conceived before having Ebola virus disease) should be enabled and encouraged to attend frequent antenatal care. After recovery from Ebola virus disease, WHO suggests that pregnant women receive counselling and information on infection prevention and control and pregnancy management by provision of respectful care and the observation of women's choices in pregnancy continuation or safe abortion to the full extent of the law.
doi_str_mv 10.1016/S1473-3099(20)30375-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2418730055</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1473309920303753</els_id><sourcerecordid>2418730055</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-9bb165bfe934601fe1809f2c7c064d88b3200be1e93c8d752e08d37ad9e47c5b3</originalsourceid><addsrcrecordid>eNqFkD1v1TAUhi0EoqXwE0CWWMoQevx1nUwIVYUiVe0AiIHB8sfJJVViX-wE2n-Pe1M6sDDZsp_3PUcPIS8ZvGXANiefmdSiEdB1xxzeCBBaNeIROazPspFS6cf7-4ockGelXAMwzUA-JQeCq06B5Ifk-yX-pt_Or-h2GQKOQ8RCU6TzD6STjXaLE8aZpp7uMm6jjf6W2hioy2jL3COGIW7psAZ8ijPe7Okzl0b7nDzp7Vjwxf15RL5-OPtyet5cXH38dPr-ovFSwtx0zrGNcj12Qm6A9cha6HrutYeNDG3rBAdwyOq_b4NWHKENQtvQodReOXFEjtfeXU4_FyyzmYbicRxtxLQUwyVrtQBQqqKv_0Gv05Jj3a5SlasWeVcptVI-p1Iy9maXh8nmW8PA3Nk3e_vmTq3hYPb2jai5V_fti5swPKT-6q7AuxXAquPXgNkUP2D0VWNGP5uQhv-M-ANTp5K3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2424137529</pqid></control><display><type>article</type><title>New WHO guidelines on the management of pregnancy and breastfeeding in the context of Ebola</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Thorson, Anna E ; Foeller, Megan E ; Caluwaerts, Severine ; Ribeiro do Valle, Carolina ; Crozier, Ian ; Deen, Gibrilla ; Dixit, Devika ; Godwin, Chrissy ; Okong, Pius ; Esteves Soeiro, Rachel ; Sousa, João Paulo ; van Herp, Michel ; Bucagu, Maurice ; Costa, Alejandro ; Foeller, Megan ; Formenty, Pierre ; Gill, Roopan ; Kim, Caron ; Kini, Brigitte ; Legand, Anais ; Oladapo, Olufemi ; Ouedraogo, Leopold ; Perkins, Mark ; Thorson, Anne ; Titulaer, Patricia</creator><creatorcontrib>Thorson, Anna E ; Foeller, Megan E ; Caluwaerts, Severine ; Ribeiro do Valle, Carolina ; Crozier, Ian ; Deen, Gibrilla ; Dixit, Devika ; Godwin, Chrissy ; Okong, Pius ; Esteves Soeiro, Rachel ; Sousa, João Paulo ; van Herp, Michel ; Bucagu, Maurice ; Costa, Alejandro ; Foeller, Megan ; Formenty, Pierre ; Gill, Roopan ; Kim, Caron ; Kini, Brigitte ; Legand, Anais ; Oladapo, Olufemi ; Ouedraogo, Leopold ; Perkins, Mark ; Thorson, Anne ; Titulaer, Patricia ; Ebola in Pregnancy and Breastfeeding Guideline Group (see appendix)</creatorcontrib><description>Furthermore, in the context of rigorous research or in accordance with the Consultation on Monitored Emergency Use of Unregistered and Investigational Interventions (known as MEURI) protocol,4 investigational therapies REGN-EB3 or mAb114 can be offered to pregnant women with Ebola virus disease. [...]2019, most pregnant women with Ebola virus disease were denied investigational therapeutics because of a paucity of drug safety data and concern for fetal harm. All pregnant women with acute Ebola virus disease should be cared for by use of both standard and Ebola-specific infection prevention and control measures, and all pregnant women who have recovered from Ebola virus disease (and who conceived before having Ebola virus disease) should be enabled and encouraged to attend frequent antenatal care. After recovery from Ebola virus disease, WHO suggests that pregnant women receive counselling and information on infection prevention and control and pregnancy management by provision of respectful care and the observation of women's choices in pregnancy continuation or safe abortion to the full extent of the law.</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(20)30375-3</identifier><identifier>PMID: 32595042</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Adult ; Breast feeding ; Breast Feeding - adverse effects ; Breastfeeding &amp; lactation ; Context ; Disease ; Disease Outbreaks - prevention &amp; control ; Disease prevention ; Ebola virus ; Ebolavirus ; Epidemics ; Female ; Fetuses ; Guidelines as Topic - standards ; Hemorrhagic Fever, Ebola - complications ; Hemorrhagic Fever, Ebola - mortality ; Humans ; Immunization ; Infant, Newborn ; Infection Control - standards ; Infections ; Infectious diseases ; Internationality ; Mortality ; Pharmacovigilance ; Pregnancy ; Prevention ; Uterus ; Vaccines ; Viral diseases ; Womens health ; World Health Organization</subject><ispartof>The Lancet infectious diseases, 2020-07, Vol.20 (7), p.766-767</ispartof><rights>2020 Elsevier Ltd</rights><rights>2020. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-9bb165bfe934601fe1809f2c7c064d88b3200be1e93c8d752e08d37ad9e47c5b3</citedby><cites>FETCH-LOGICAL-c440t-9bb165bfe934601fe1809f2c7c064d88b3200be1e93c8d752e08d37ad9e47c5b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2424137529?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32595042$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thorson, Anna E</creatorcontrib><creatorcontrib>Foeller, Megan E</creatorcontrib><creatorcontrib>Caluwaerts, Severine</creatorcontrib><creatorcontrib>Ribeiro do Valle, Carolina</creatorcontrib><creatorcontrib>Crozier, Ian</creatorcontrib><creatorcontrib>Deen, Gibrilla</creatorcontrib><creatorcontrib>Dixit, Devika</creatorcontrib><creatorcontrib>Godwin, Chrissy</creatorcontrib><creatorcontrib>Okong, Pius</creatorcontrib><creatorcontrib>Esteves Soeiro, Rachel</creatorcontrib><creatorcontrib>Sousa, João Paulo</creatorcontrib><creatorcontrib>van Herp, Michel</creatorcontrib><creatorcontrib>Bucagu, Maurice</creatorcontrib><creatorcontrib>Costa, Alejandro</creatorcontrib><creatorcontrib>Foeller, Megan</creatorcontrib><creatorcontrib>Formenty, Pierre</creatorcontrib><creatorcontrib>Gill, Roopan</creatorcontrib><creatorcontrib>Kim, Caron</creatorcontrib><creatorcontrib>Kini, Brigitte</creatorcontrib><creatorcontrib>Legand, Anais</creatorcontrib><creatorcontrib>Oladapo, Olufemi</creatorcontrib><creatorcontrib>Ouedraogo, Leopold</creatorcontrib><creatorcontrib>Perkins, Mark</creatorcontrib><creatorcontrib>Thorson, Anne</creatorcontrib><creatorcontrib>Titulaer, Patricia</creatorcontrib><creatorcontrib>Ebola in Pregnancy and Breastfeeding Guideline Group (see appendix)</creatorcontrib><title>New WHO guidelines on the management of pregnancy and breastfeeding in the context of Ebola</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>Furthermore, in the context of rigorous research or in accordance with the Consultation on Monitored Emergency Use of Unregistered and Investigational Interventions (known as MEURI) protocol,4 investigational therapies REGN-EB3 or mAb114 can be offered to pregnant women with Ebola virus disease. [...]2019, most pregnant women with Ebola virus disease were denied investigational therapeutics because of a paucity of drug safety data and concern for fetal harm. All pregnant women with acute Ebola virus disease should be cared for by use of both standard and Ebola-specific infection prevention and control measures, and all pregnant women who have recovered from Ebola virus disease (and who conceived before having Ebola virus disease) should be enabled and encouraged to attend frequent antenatal care. After recovery from Ebola virus disease, WHO suggests that pregnant women receive counselling and information on infection prevention and control and pregnancy management by provision of respectful care and the observation of women's choices in pregnancy continuation or safe abortion to the full extent of the law.</description><subject>Adult</subject><subject>Breast feeding</subject><subject>Breast Feeding - adverse effects</subject><subject>Breastfeeding &amp; lactation</subject><subject>Context</subject><subject>Disease</subject><subject>Disease Outbreaks - prevention &amp; control</subject><subject>Disease prevention</subject><subject>Ebola virus</subject><subject>Ebolavirus</subject><subject>Epidemics</subject><subject>Female</subject><subject>Fetuses</subject><subject>Guidelines as Topic - standards</subject><subject>Hemorrhagic Fever, Ebola - complications</subject><subject>Hemorrhagic Fever, Ebola - mortality</subject><subject>Humans</subject><subject>Immunization</subject><subject>Infant, Newborn</subject><subject>Infection Control - standards</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Internationality</subject><subject>Mortality</subject><subject>Pharmacovigilance</subject><subject>Pregnancy</subject><subject>Prevention</subject><subject>Uterus</subject><subject>Vaccines</subject><subject>Viral diseases</subject><subject>Womens health</subject><subject>World Health Organization</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkD1v1TAUhi0EoqXwE0CWWMoQevx1nUwIVYUiVe0AiIHB8sfJJVViX-wE2n-Pe1M6sDDZsp_3PUcPIS8ZvGXANiefmdSiEdB1xxzeCBBaNeIROazPspFS6cf7-4ockGelXAMwzUA-JQeCq06B5Ifk-yX-pt_Or-h2GQKOQ8RCU6TzD6STjXaLE8aZpp7uMm6jjf6W2hioy2jL3COGIW7psAZ8ijPe7Okzl0b7nDzp7Vjwxf15RL5-OPtyet5cXH38dPr-ovFSwtx0zrGNcj12Qm6A9cha6HrutYeNDG3rBAdwyOq_b4NWHKENQtvQodReOXFEjtfeXU4_FyyzmYbicRxtxLQUwyVrtQBQqqKv_0Gv05Jj3a5SlasWeVcptVI-p1Iy9maXh8nmW8PA3Nk3e_vmTq3hYPb2jai5V_fti5swPKT-6q7AuxXAquPXgNkUP2D0VWNGP5uQhv-M-ANTp5K3</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Thorson, Anna E</creator><creator>Foeller, Megan E</creator><creator>Caluwaerts, Severine</creator><creator>Ribeiro do Valle, Carolina</creator><creator>Crozier, Ian</creator><creator>Deen, Gibrilla</creator><creator>Dixit, Devika</creator><creator>Godwin, Chrissy</creator><creator>Okong, Pius</creator><creator>Esteves Soeiro, Rachel</creator><creator>Sousa, João Paulo</creator><creator>van Herp, Michel</creator><creator>Bucagu, Maurice</creator><creator>Costa, Alejandro</creator><creator>Foeller, Megan</creator><creator>Formenty, Pierre</creator><creator>Gill, Roopan</creator><creator>Kim, Caron</creator><creator>Kini, Brigitte</creator><creator>Legand, Anais</creator><creator>Oladapo, Olufemi</creator><creator>Ouedraogo, Leopold</creator><creator>Perkins, Mark</creator><creator>Thorson, Anne</creator><creator>Titulaer, Patricia</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>202007</creationdate><title>New WHO guidelines on the management of pregnancy and breastfeeding in the context of Ebola</title><author>Thorson, Anna E ; Foeller, Megan E ; Caluwaerts, Severine ; Ribeiro do Valle, Carolina ; Crozier, Ian ; Deen, Gibrilla ; Dixit, Devika ; Godwin, Chrissy ; Okong, Pius ; Esteves Soeiro, Rachel ; Sousa, João Paulo ; van Herp, Michel ; Bucagu, Maurice ; Costa, Alejandro ; Foeller, Megan ; Formenty, Pierre ; Gill, Roopan ; Kim, Caron ; Kini, Brigitte ; Legand, Anais ; Oladapo, Olufemi ; Ouedraogo, Leopold ; Perkins, Mark ; Thorson, Anne ; Titulaer, Patricia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-9bb165bfe934601fe1809f2c7c064d88b3200be1e93c8d752e08d37ad9e47c5b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Breast feeding</topic><topic>Breast Feeding - adverse effects</topic><topic>Breastfeeding &amp; lactation</topic><topic>Context</topic><topic>Disease</topic><topic>Disease Outbreaks - prevention &amp; control</topic><topic>Disease prevention</topic><topic>Ebola virus</topic><topic>Ebolavirus</topic><topic>Epidemics</topic><topic>Female</topic><topic>Fetuses</topic><topic>Guidelines as Topic - standards</topic><topic>Hemorrhagic Fever, Ebola - complications</topic><topic>Hemorrhagic Fever, Ebola - mortality</topic><topic>Humans</topic><topic>Immunization</topic><topic>Infant, Newborn</topic><topic>Infection Control - standards</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Internationality</topic><topic>Mortality</topic><topic>Pharmacovigilance</topic><topic>Pregnancy</topic><topic>Prevention</topic><topic>Uterus</topic><topic>Vaccines</topic><topic>Viral diseases</topic><topic>Womens health</topic><topic>World Health Organization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thorson, Anna E</creatorcontrib><creatorcontrib>Foeller, Megan E</creatorcontrib><creatorcontrib>Caluwaerts, Severine</creatorcontrib><creatorcontrib>Ribeiro do Valle, Carolina</creatorcontrib><creatorcontrib>Crozier, Ian</creatorcontrib><creatorcontrib>Deen, Gibrilla</creatorcontrib><creatorcontrib>Dixit, Devika</creatorcontrib><creatorcontrib>Godwin, Chrissy</creatorcontrib><creatorcontrib>Okong, Pius</creatorcontrib><creatorcontrib>Esteves Soeiro, Rachel</creatorcontrib><creatorcontrib>Sousa, João Paulo</creatorcontrib><creatorcontrib>van Herp, Michel</creatorcontrib><creatorcontrib>Bucagu, Maurice</creatorcontrib><creatorcontrib>Costa, Alejandro</creatorcontrib><creatorcontrib>Foeller, Megan</creatorcontrib><creatorcontrib>Formenty, Pierre</creatorcontrib><creatorcontrib>Gill, Roopan</creatorcontrib><creatorcontrib>Kim, Caron</creatorcontrib><creatorcontrib>Kini, Brigitte</creatorcontrib><creatorcontrib>Legand, Anais</creatorcontrib><creatorcontrib>Oladapo, Olufemi</creatorcontrib><creatorcontrib>Ouedraogo, Leopold</creatorcontrib><creatorcontrib>Perkins, Mark</creatorcontrib><creatorcontrib>Thorson, Anne</creatorcontrib><creatorcontrib>Titulaer, Patricia</creatorcontrib><creatorcontrib>Ebola in Pregnancy and Breastfeeding Guideline Group (see appendix)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thorson, Anna E</au><au>Foeller, Megan E</au><au>Caluwaerts, Severine</au><au>Ribeiro do Valle, Carolina</au><au>Crozier, Ian</au><au>Deen, Gibrilla</au><au>Dixit, Devika</au><au>Godwin, Chrissy</au><au>Okong, Pius</au><au>Esteves Soeiro, Rachel</au><au>Sousa, João Paulo</au><au>van Herp, Michel</au><au>Bucagu, Maurice</au><au>Costa, Alejandro</au><au>Foeller, Megan</au><au>Formenty, Pierre</au><au>Gill, Roopan</au><au>Kim, Caron</au><au>Kini, Brigitte</au><au>Legand, Anais</au><au>Oladapo, Olufemi</au><au>Ouedraogo, Leopold</au><au>Perkins, Mark</au><au>Thorson, Anne</au><au>Titulaer, Patricia</au><aucorp>Ebola in Pregnancy and Breastfeeding Guideline Group (see appendix)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>New WHO guidelines on the management of pregnancy and breastfeeding in the context of Ebola</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2020-07</date><risdate>2020</risdate><volume>20</volume><issue>7</issue><spage>766</spage><epage>767</epage><pages>766-767</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><abstract>Furthermore, in the context of rigorous research or in accordance with the Consultation on Monitored Emergency Use of Unregistered and Investigational Interventions (known as MEURI) protocol,4 investigational therapies REGN-EB3 or mAb114 can be offered to pregnant women with Ebola virus disease. [...]2019, most pregnant women with Ebola virus disease were denied investigational therapeutics because of a paucity of drug safety data and concern for fetal harm. All pregnant women with acute Ebola virus disease should be cared for by use of both standard and Ebola-specific infection prevention and control measures, and all pregnant women who have recovered from Ebola virus disease (and who conceived before having Ebola virus disease) should be enabled and encouraged to attend frequent antenatal care. After recovery from Ebola virus disease, WHO suggests that pregnant women receive counselling and information on infection prevention and control and pregnancy management by provision of respectful care and the observation of women's choices in pregnancy continuation or safe abortion to the full extent of the law.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>32595042</pmid><doi>10.1016/S1473-3099(20)30375-3</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1473-3099
ispartof The Lancet infectious diseases, 2020-07, Vol.20 (7), p.766-767
issn 1473-3099
1474-4457
language eng
recordid cdi_proquest_miscellaneous_2418730055
source MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland
subjects Adult
Breast feeding
Breast Feeding - adverse effects
Breastfeeding & lactation
Context
Disease
Disease Outbreaks - prevention & control
Disease prevention
Ebola virus
Ebolavirus
Epidemics
Female
Fetuses
Guidelines as Topic - standards
Hemorrhagic Fever, Ebola - complications
Hemorrhagic Fever, Ebola - mortality
Humans
Immunization
Infant, Newborn
Infection Control - standards
Infections
Infectious diseases
Internationality
Mortality
Pharmacovigilance
Pregnancy
Prevention
Uterus
Vaccines
Viral diseases
Womens health
World Health Organization
title New WHO guidelines on the management of pregnancy and breastfeeding in the context of Ebola
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T02%3A37%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=New%20WHO%20guidelines%20on%20the%20management%20of%20pregnancy%20and%20breastfeeding%20in%20the%20context%20of%20Ebola&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Thorson,%20Anna%20E&rft.aucorp=Ebola%20in%20Pregnancy%20and%20Breastfeeding%20Guideline%20Group%20(see%20appendix)&rft.date=2020-07&rft.volume=20&rft.issue=7&rft.spage=766&rft.epage=767&rft.pages=766-767&rft.issn=1473-3099&rft.eissn=1474-4457&rft_id=info:doi/10.1016/S1473-3099(20)30375-3&rft_dat=%3Cproquest_cross%3E2418730055%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2424137529&rft_id=info:pmid/32595042&rft_els_id=S1473309920303753&rfr_iscdi=true